| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biome Grow Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$0.015 |
| 52 Week Low | CA$0.005 |
| Beta | -0.13 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -50.00% |
| 3 Year Change | -93.75% |
| 5 Year Change | -99.06% |
| Change since IPO | -99.74% |
Recent News & Updates
Shareholder Returns
| BIO | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -0.6% |
| 1Y | -50.0% | 50.8% | 3.9% |
Return vs Industry: BIO underperformed the Canadian Pharmaceuticals industry which returned 50.8% over the past year.
Return vs Market: BIO underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| BIO volatility | |
|---|---|
| BIO Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.9% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: BIO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BIO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Khurram Malik | www.biomegrow.com |
Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.
Biome Grow Inc. Fundamentals Summary
| BIO fundamental statistics | |
|---|---|
| Market cap | CA$562.09k |
| Earnings (TTM) | -CA$2.13m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.3x
P/E RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIO income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.13m |
| Earnings | -CA$2.13m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -86.7% |
How did BIO perform over the long term?
See historical performance and comparison